Immunic is trading 5.16% down at $8.82, with no clear company-specific catalyst identified for the October 1, 2026 decline in available search results. - The company’s investor-relations page lists September 29 inducement grants as its latest release, with no new October 1 announcement. - Broader indexes were mixed-to-lower in the supplied market context, but this does not establish a direct cause for Immunic’s move.